← Eichor
Study identifier: NCT06885502 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Personalised Health Motor and Cognitive Assistance System for RehAbilitation (PHRASE)

Condition: Stroke · Stroke Rehabilitation · Chronic Stroke Patients  ·  Sponsor: Eodyne Systems SL

PhaseNA
Planned participants70
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This study is a multicentric randomized controlled trial evaluating the effectiveness of digital technology, specifically a smartphone with integrated VR-and AR-based intervention, for at-home rehabilitation after stroke. The study focuses on combined motor and cognitive training for patients in the late subacute and chronic phases post-stroke. The intervention is provided through the Rehabilitation Gaming System application RGSapp, a goal-oriented, first-person virtual reality (VR) and augmented reality (AR) mobile application for upper limb rehabilitation. A total of seventy participants will be randomly assigned (1:1 ratio) to either the RGSapp intervention or conventional therapy/standard of care for six weeks. The primary outcome is motor function improvement (upper limb), assessed using the Action Research Arm Test (ARAT). Secondary outcomes include changes in cognitive function, depression, usability, adherence, validity of remote assessments, and healthcare costs.

This description comes directly from the study's public registry record.

Talk to the study team

Santiago Brandi  ·  34 931389642  ·  contact@eodyne.com

Anna Mura  ·  anna3.mura@gmail.com

Always discuss trial participation with your own doctor first.

Locations (2)

RoNeuro Institute for Neurological Research and DiagnosticsCluj-Napoca, RomaniaRecruiting
Hospital Universitari Joan XXIII de TarragonaTarragona, SpainRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06885502